| Yazarlar (1) |
Doç. Dr. Ziya ASAN
Kırşehir Ahi Evran Üniversitesi, Türkiye |
| Özet |
| Objective Although nonpenetrating spinal cord injuries are rare cases, they are the ideal cases in which the effectiveness of Methylprednisolone treatment can be determined. MP therapy can prevent the transformation of a spinal injury from neuropraxia to axonotmesis or neurotmesis. This study aims to show the effectiveness of MP therapy in cases with nonpenetrating spinal cord injury. It is aimed to show that it can facilitate both treatment and early differential diagnosis in cases that cannot be diagnosed at the time of admission. Material and Methods Cases diagnosed with nonpenetrating spinal cord injury were grouped as Spinal concussion, SCIWORA, and Real SCIWORA. Neurological findings were recorded according to the process in the cases given or not given MP therapy in the early diagnosis and treatment phase. Results Data of 75 cases in total were evaluated. Sixty cases were diagnosed with a spinal concussion, 9 with SCIWORA, and 6 with Real SCIWORA. The rate of improvement in neurological deficits was found to be higher in patients who were treated with methylprednisolone in all three groups. Differential diagnosis could be made between early treatment responses. Segmentary asymmetric neurological findings in spinal injury cases may indicate that different degrees of injury have developed in different spinal cord regions. Conclusions MP therapy can terminate or slow down neuropraxia in spinal injuries and prevent more advanced injuries. Although it is adequate for treatment purposes, it can also help make a definitive diagnosis at the time of application. |
| Anahtar Kelimeler |
| Makale Türü | Özgün Makale |
| Makale Alt Türü | Uluslararası alan indekslerindeki dergilerde yayınlanan tam makale |
| Dergi Adı | Research and Clinical Medicine |
| Dergi ISSN | 2360-1124 |
| Dergi Tarandığı Indeksler | DOAJ, INDEX COPERNICUS |
| Makale Dili | İngilizce |
| Basım Tarihi | 01-2022 |
| Cilt No | 6 |
| Sayı | 1 |
| Sayfalar | 18 / 23 |
| Makale Linki | https://www.resclinmed.eu/public/data_files/articles/151/article_151.pdf |
